Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21492.
Pinto AP, Crum CP. Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol. 2000. https://doi.org/10.1097/00003081-200006000-00015.
Klöppel Günter, Dietel M, Remmele. Wolfgang. Pathologie. Mamma, Weibliches Genitale, Schwangerschaft und Kindererkrankungen. 3., neubearb. Aufl. Berlin: Springer Berlin (Pathologie); 2013.
Nkwabong E, Laure Bessi Badjan I, Sando Z. Pap smear accuracy for the diagnosis of cervical precancerous lesions. Trop Doct. 2019. https://doi.org/10.1177/0049475518798532.
Kocken M, Helmerhorst TJ, Berkhof J, Louwers JA, Nobbenhuis MA, Bais AG, Hogewoning CJ, Zaal A, Verheijen RH, Snijders PJ, Meijer CJ. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol. 2011. https://doi.org/10.1016/S1470-2045(11)70078-X.
Andersson S, Megyessi D, Belkić K, Alder S, Östensson E, Mints M. Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment. Oncol Lett. 2021. https://doi.org/10.3892/ol.2021.12945.
Feng H, Chen H, Huang D, He S, Xue Z, Pan Z, Yu H, Huang Y. Relationship between positive margin and residual/recurrence after excision of cervical intraepithelial neoplasia: a systematic review and meta-analysis. Transl Cancer Res. 2022. https://doi.org/10.21037/tcr-22-1466.
Di Donato V, Caruso G, Petrillo M, Kontopantelis E, Palaia I, Perniola G, Plotti F, Angioli R, Muzii L, Benedetti Panici P, Bogani G. Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after Surgical Treatment: a Meta-analysis. Vaccines (Basel). 2021. https://doi.org/10.3390/vaccines9050410.
Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P, Casarin J, Pinelli C, Ghezzi F, De Vincenzo R, Di Donato V, Golia D’augè T, Giannini A, Sorbi F, Petrillo M, Capobianco G, Vizzielli G, Restaino S, Cianci S, Scambia G, Raspagliesi F. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: a focus on the potential role of vaccination. Tumori. 2024. https://doi.org/10.1177/03008916231208344).
Jentschke M, Kampers J, Becker J, Sibbertsen P, Hillemanns P. Prophylactic HPV vaccination after conization: a systematic review and meta-analysis. Vaccine. 2020. https://doi.org/10.1016/j.vaccine.2020.07.055.
Giannini A, Bogani G. Outcomes of high-Grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines (Basel). 2023. https://doi.org/10.3390/vaccines11030698.
Cuello MA, Espinosa ME, Orlandini EJ, Hwang DY. The value of endocervical curettage during loop electrosurgical excision procedures in predicting persistent/recurrent preinvasive cervical disease. Int J Gynaecol Obstet. 2018. https://doi.org/10.1002/ijgo.12480.
Kühn W. Die aktuellen Empfehlungen der AG-CPC zur Kolposkopie 2015. In: Gyn. Praktische Gynäkologie. 2015. https://www.ag-cpc.de/wp-content/uploads/2018/07/Gieseking-Empf-AG-CPC.pdf. Accessed 20 July 2024.
Bowden SJ, Doulgeraki T, Bouras E, Markozannes G, Athanasiou A, Grout-Smith H, Kechagias KS, Ellis LB, Zuber V, Chadeau-Hyam M, Flanagan JM, Tsilidis KK, Kalliala I, Kyrgiou M. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up mendelian randomisation studies. BMC Med. 2023. https://doi.org/10.1186/s12916-023-02965-w.
Zang L, Hu Y. Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion. Arch Gynecol Obstet. 2021. https://doi.org/10.1007/s00404-021-06217-1.
Cao D, Shen K, Chen Y, Xu Y, Wu D. Value of endocervical curettage in follow-up for patients with cervical intraepithelial neoplasia stage 2 + after loop electrosurgical excision. Gynecol Oncol. 2020. https://doi.org/10.1016/j.ygyno.2020.06.490.
Arbyn M, Redman CWE, Verdoodt F, Kyrgiou M, Tzafetas M, Ghaem-Maghami S, Petry KU, Leeson S, Bergeron C, Nieminen P, Gondry J, Reich O, Moss EL. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017. https://doi.org/10.1016/S1470-2045(17)30700-3.
Liu L, Chen LM, Tao X, Dai F, Guo LP, Zhang HW, Zhou XR, Sui L. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases]. Zhonghua Fu Chan Ke Za Zhi. 2017. https://doi.org/10.3760/cma.j.issn.0529-567X.2017.11.007
Simões RB, Campaner AB. Post-cervical conization outcomes in patients with high-grade intraepithelial lesions. APMIS. 2013. https://doi.org/10.1111/apm.12064.
Fernández-Montolí ME, Tous S, Medina G, Castellarnau M, García-Tejedor A, de Sanjosé S. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2–3 after treatment with a large loop excision of the transformation zone: a retrospective study. BJOG. 2020. https://doi.org/10.1111/1471-0528.15996.
Zivadinović R, Lilić V, Petrić A, Tubić A. Prognostic and therapeutic implication of residual tumorous tissue in cervix conizate. Vojnosanit Pregl. 2007. https://doi.org/10.2298/vsp0701031z.
Takeda N, Suzuki T, Suzuki M, Matsuura M, Tanaka R, Fujii M, Ito E, Saito T. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. Arch Gynecol Obstet. 2012. https://doi.org/10.1007/s00404-011-1944-4.
Gosvig CF, Huusom LD, Deltour I, Andersen KK, Duun-Henriksen AK, Madsen EM, Petersen LK, Elving L, Schouenbourg L, Iftner A, Svare E, Iftner T, Kjaer SK. Role of human papillomavirus testing and cytology in follow-up after conization. Acta Obstet Gynecol Scand. 2015. https://doi.org/10.1111/aogs.12601.
Baloglu A, Uysal D, Bezircioglu I, Bicer M, Inci A. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Arch Gynecol Obstet. 2010. https://doi.org/10.1007/s00404-009-1298-3.
Cho HY, Kim YB, Hong No J, Kim K. Endocervical margin involvement as an important risk factor for abnormal cytology after LLETZ. Int J Gynecol Pathol. 2012. https://doi.org/10.1097/PGP.0b013e31823ef970.
Chen LM, Liu L, Tao X, He Y, Guo LP, Zhang HW, Zhou XR, Sui L. Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP]. Zhonghua Fu Chan Ke Za Zhi. 2019. https://doi.org/10.3760/cma.j.issn.0529-567x.2019.08.006.
Fine BA, Feinstein GI, Sabella V. The pre- and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer. Gynecol Oncol. 1998. https://doi.org/10.1006/gyno.1998.5120.
Alder S, Megyessi D, Sundström K, Östensson E, Mints M, Belkić K, Arbyn M, Andersson S. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study. Am J Obstet Gynecol. 2020. https://doi.org/10.1016/j.ajog.2019.08.042.
Bjørnerem MS, Sørbye SW, Skjeldestad FE. Recurrent disease after treatment for cervical intraepithelial neoplasia-the importance of a flawless definition of residual disease and length of follow-up. Eur J Obstet Gynecol Reprod Biol. 2020. https://doi.org/10.1016/j.ejogrb.2020.03.022.
Duesing N, Schwarz J, Choschzick M, Jaenicke F, Gieseking F, Issa R, Mahner S, Woelber L. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP). Arch Gynecol Obstet. 2012. https://doi.org/10.1007/s00404-012-2493-1.
Alukal AT, Rema P, Suchetha S, Dinesh D, Mathew A, Krishna KMJ, Somanathan T, Sivaranjith J. Evaluation of factors affecting Margin Positivity and Persistent Disease after Leep for Cervical Intraepithelial Neoplasia. J Obstet Gynaecol India. 2021. https://doi.org/10.1007/s13224-021-01450-9.
Bogani G, Raspagliesi F. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser conization: a 5-year follow-up study. Gynecol Oncol. 2020. https://doi.org/10.1016/j.ygyno.2020.08.025.
Abdulaziz AMA, You X, Liu L, Sun Y, Zhang J, Sun S, Li X, Sun W, Dong Y, Liu H, Zhang Y. Management of high-grade squamous intraepithelial lesion patients with positive margin after LEEP conization: a retrospective study. Med (Baltim). 2021. https://doi.org/10.1097/MD.0000000000026030.
Chen JY, Wang ZL, Wang ZY, Yang XS. The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization. Med (Baltim). 2018. https://doi.org/10.1097/MD.0000000000012792.
Bruhn LV, Andersen SJ, Hariri J. HPV-testing versus HPV-cytology co-testing to predict the outcome after conization. Acta Obstet Gynecol Scand. 2018. https://doi.org/10.1111/aogs.13325.
Fu Y, Chen C, Feng S, Cheng X, Wang X, Xie X, Lü W. Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization. Ther Clin Risk Manag. 2015. https://doi.org/10.2147/TCRM.S81802.
Li Y, Luo H, Zhang X, Chang J, Zhao Y, Li J, Li D, Wang W. Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions. BMC Cancer. 2021. https://doi.org/10.1186/s12885-021-08523-y.
Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Comparative risk of high-grade histopathology diagnosis after a CIN 1 finding in endocervical curettage versus cervical biopsy. J Low Genit Tract Dis. 2013. https://doi.org/10.1097/LGT.0b013e3182630c41.
Shepherd JP, Guido R, Lowder JL. Should endocervical curettage routinely be performed at the time of colposcopy? A cost-effectiveness analysis. J Low Genit Tract Dis. 2014. https://doi.org/10.1097/LGT.0b013e3182a0b572.
Lang L, Jia Y, Duan Z, Wu J, Luo M, Tian P. The role of endocervical curettage in detection and treatment of cervical canal lesions. Histol Histopathol. 2022. https://doi.org/10.14670/HH-18-394.
Chikazawa K, Netsu S, Motomatsu S, Konno R. Predictors of recurrent/residual disease after loop electrosurgical excisional procedure. J Obstet Gynaecol Res. 2016. https://doi.org/10.1111/jog.12929.
Shaco-Levy R, Meirovitz M, Eger G, Benharroch D, Dreiher J. Post-conization endocervical curettage for estimating the risk of persistent or recurrent high-grade dysplasia. Int J Gynaecol Obstet. 2013. https://doi.org/10.1016/j.ijgo.2012.10.029.
Cejtin HE, Zimmerman L, Mathews M, Patel A. Predictors of persistent or recurrent Disease after Loop Electrosurgical Excision Procedure. J Low Genit Tract Dis. 2017. https://doi.org/10.1097/LGT.0000000000000276.
Add Comment